Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma
Clinical trial NCT04189952 · TERMINATED
Trial details
- NCT number
- NCT04189952
- Sponsor
- University of Miami
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2021-06-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.